Spring Wang

Spring Wang is currently the Director of Medical/Regulatory Affairs and Quality Assurance for Greater China at CSL Behring, where they focus on medical strategy, regulatory affairs, and quality assurance in plasma product manufacturing. Previously, Spring held positions such as Senior Medical Director for APAC at Cephalon Inc and Regional Clinical Director for APAC at St. Jude Medical. Spring also served as Medical Director for Oncology Clinical Research at Eli Lilly and Company and Director of Global Clinical Operations for Johnson & Johnson. They obtained a Master of Science in Clinical Sciences from the National University of Singapore in 2002.